Persons with multiple chronic conditions are a large and growing segment of the US
population. However, little is known about how chronic conditions cluster, and the …

Biochemical marker testing has revolutionized the approach to diagnosis and management
of heart failure over the past decade. There is an unsurpassed excitement in the heart failure …

Полиморбидность является одной из особенностей современной клиники внутренних
болезней, а ишемическая болезнь сердца (ИБС), артериальная гипертензия и …

Aims: To investigate the prevalence and the prognostic impact of chronic obstructive
pulmonary disease (COPD), in patients hospitalised with chronic heart failure (CHF) …

Chronic obstructive pulmonary disease (COPD) is increasingly recognized as a major health
care problem and the number of publications in the scientific literature is a reflection of this …

Background B‐type natriuretic peptide (BNP) levels significantly predict increased risk of
death in heart failure. The predictive role of BNP levels in patients with non‐cardiac causes …

Clinical trials have consistently shown the benefits of beta-blocker treatment in patients with
chronic heart failure (HF). As a result, bisoprolol, carvedilol, and metoprolol succinate are …

Patients who have mild to severe chronic obstructive pulmonary disease may obtain
improvement in dyspnea, exercise capacity, and health-related quality of life as a result of …

Zusammenfassung Der rechte Ventrikel toleriert Volumenbelastungen durch Rekrutierung
von Kapazitätsgefäßen und Kapillaren des Lungenkreislaufs ohne wesentliche …

Untitled Page 1 Page 2 Chronic obstructive pulmonary disease (COPD) is a leading cause of
morbidity and mortality and an increasing economic problem worldwide [1]. Progressively …